Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions

Iranian Journal of Diabetes and Lipid Disorders

Volumn 6, Issue 4, 2007, Pages

  Hadaegh, Farzad ^a,b   Zabetian, Azadeh ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Taleghani Hospital   (Iran)

Author keywords

Concordance; Kappa; Metabolic syndrome; Prevalence

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; STATISTICAL ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 37249077384     PISSN: 17267544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care 2001; 24: 683-9.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA 2002; 288: 2709-16.
3. Alberti KG, Zimmet PZ, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med 1998; 15: 539-53.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA 2001; 285: 2486-97.
5. Balkau B, Charles MA, Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-3.
6. International Diabetes Federation Press Conference: The IDF consensus worldwide definition of the metabolic syndrome [article online], 2005. Available from http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed 14 April 2005
7. Ford ES, Giles WH, A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-81.
8. Ford ES, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28: 2745-9.
9. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP, The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 1157-9.
10. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29-37.
11. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gomez-Gerique JA, et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 2003; 11: 1480-7.
12. Raymond SU, Leeder S, Greenberg HM, Obesity and cardiovascular disease in developing countries: a growing problem and an economic threat. Curr Opin Clin Nutr Metab Care 2006; 9: 111-6.
13. Prentice AM, The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93-9.
14. Azizi F, Azadbakht L, Mirmiran P, Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann Nutr Metab 2005; 49: 3-8.
15. Azadbakht L, Mirmiran P, Shiva N, Azizi F, General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res 2005; 75: 297-304.
16. Rashidi A, Mohammadpour-Ahranjani B, Vafa MR, Karandish M, Prevalence of obesity in Iran. Obes Rev 2005; 6: 191-2.
17. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 2002; 47: 408-26.
18. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA, Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-7.
19. Balkau B, Charles MA, Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-3.
20. Ahmad O, Boschi-Pinto C, Lopez A, Murray CJL, Lozano R, Inoue M, Age Standardization of Rates: a New WHO Standard (GPE Discussion Paper Series No. 31). Geneva: World Health Organization, 2000.
21. Altman DG, Some Practical statistics for medical research. First edition Champan and Hall, 1991, P. 404.
22. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, et al. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care 2003; 26: 1635.
23. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF, Metabolic syndrome and coronary heart disease in South Asians, African-Caribbean and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005; 48: 649-56.
24. Jorgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K, Greenland Population Study. Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabet Med 2004; 21: 1237-42.
25. Martinez Candela J, Franch Nadal J, Romero Ortiz J, Canovas Dominguez C, Gallardo Martin A, Paez Perez M, Prevalence of metabolic syndrome in the adult population of yecla (murcia). Degree of agreement between three definitions of it. Aten Primaria 2006; 38: 72-9.
26. Rathmann W, Haastert B, Icks A, Giani G, Holle R, Koenig W, et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care 2006; 29: 461.
27. Deepa M, Farooq S, Datta M, Deepa R, Mohan V, Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34), Diabetes Metab Res Rev 2006; [Epub ahead of print].
28. Ko GT, Cockram CS, Chow CC, Yeung VT, Chan WB, So WY, et al. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract 2006; 73: 58-64.
29. Park HS, Lee SY, Kim SM, Han JH, Kim DJ, Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. Diabetes Care 2006; 29: 933-4.
30. Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, et al. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis 2002; 12: 80-9.
31. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM, Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160-7.
32. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 2006; 6: 158.
33. Guerrero-Romero F, Rodriguez-Moran M, Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 2005; 28: 2588-9.
34. Hadaegh F, Zabetian A, Harati H, Azizi F, Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men - a 3.6-year prospective study. Exp Clin Endocrinol. Diabetes 2006; 114: 310-5.